BRIEF published on 09/12/2024 at 19:05, 2 months 8 days ago Robertet: Strong growth in turnover in the first half of 2024 EBITDA Net Result ESG Turnover Robertet
PRESS RELEASE published on 09/12/2024 at 19:00, 2 months 8 days ago STRONG GROWTH IN THE FIRST HALF OF 2024 Robertet reports strong first-half 2024 results: Sales up 10.1% with organic growth at 9.6%. Recurring EBITDA margin improves to 21.4%. Positive regional and divisional performance Financial Performance EBITDA Margin Sales Growth Robertet First-Half 2024
BRIEF published on 07/25/2024 at 18:05, 3 months 26 days ago Revenue up 10.1% in the first half of 2024 Growth Turnover Robertet Raw Materials Perfumes And Aromas
PRESS RELEASE published on 07/25/2024 at 18:00, 3 months 26 days ago SALES UP 10,1% IN THE FIRST HALF OF 2024 Robertet, a world leader in natural raw materials, reports 10,1% sales growth in H1 2024. Solid performance fueled by customer momentum and divisional strengths Financial Report Sales Growth Robertet First-Half 2024 Natural Raw Materials
BRIEF published on 07/11/2024 at 18:05, 4 months 9 days ago Share Capital and Voting Rights as of July 11, 2024 for ROBERTET Euronext Paris Share Capital Voting Rights Investment Robertet
BRIEF published on 06/20/2024 at 18:05, 5 months ago Share Capital and Voting Rights as of June 14, 2024: ROBERTET SA Euronext Paris Share Capital Voting Rights AMF ROBERTET SA
BRIEF published on 05/16/2024 at 18:05, 6 months 4 days ago Robertet announces its figures relating to voting rights as of May 6, 2024 Euronext Paris Share Capital Voting Rights General Assembly Robertet
BRIEF published on 04/22/2024 at 18:05, 6 months 28 days ago Robertet announces the availability of its 2023 annual financial report Financial Report 2023 Finance Robertet Oily
BRIEF published on 04/11/2024 at 18:05, 7 months 9 days ago Robertet announces growth despite a difficult context in 2023 Inflation Growth 2023 Financial Results Internationalization Robertet
PRESS RELEASE published on 04/11/2024 at 18:00, 7 months 9 days ago 2023 RESULTS : A GOOD PERFORMANCE IN A DIFFICULT ECONOMIC CONTEXT Robertet Group reports 2.6% increase in sales to €721 million and 3.6% rise in EBITDA to €133 million for 2023. Continued international expansion with the acquisition of Sonarome in India Acquisition Financial Performance Sales Increase International Expansion Robertet Group
Published on 11/21/2024 at 13:30, 15 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 15 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 45 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 45 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 45 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 9 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 29 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
